Compared to cell-based therapies, which have issues with viability, retention, risk of tumor formation, and precise delivery within the wound environment [57,58], collagen-elastin scaffolds serve as supportive, biocompatible matrices that support proliferation and differentiation of host cells. The gene discussed is ELN; the disease is neoplasm.